In contrast, p53 was ubiquitously expressed in both components of the primary tumor (Fig. 2H), and LN no. 13, containing poorly differentiated NEC, was immunohistochemically positive for chromogranin A, synaptophysin, and NSE. The gene discussed is ENO2; the disease is neuroendocrine carcinoma.